Enhancing Oral Vaccine Potency by Targeting Intestinal M Cells

被引:134
作者
Azizi, Ali [1 ,2 ]
Kumar, Ashok [1 ,2 ]
Diaz-Mitoma, Francisco [1 ,2 ]
Mestecky, Jiri [3 ,4 ,5 ]
机构
[1] Childrens Hosp Eastern Ontario, Res Inst, Infect Dis & Vaccine Res Ctr, Ottawa, ON K1H 8L1, Canada
[2] Univ Ottawa, Dept Pathol & Lab Med, Ottawa, ON, Canada
[3] Univ Alabama, Dept Microbiol, Birmingham, AL 35294 USA
[4] Charles Univ Prague, Fac Med 1, Inst Microbiol & Immunol, Prague, Czech Republic
[5] Acad Sci Czech Republic, Inst Microbiol, Dept Immunol, Prague, Czech Republic
关键词
PATCH M-CELLS; UROPATHOGENIC ESCHERICHIA-COLI; MUCOSAL IMMUNE-SYSTEM; LACTIC-ACID BACTERIA; TOXIN-B-SUBUNIT; PEYERS PATCH; INTRANASAL IMMUNIZATION; INFLUENZA VACCINE; EPITHELIAL-CELLS; CHOLERA-TOXIN;
D O I
10.1371/journal.ppat.1001147
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The immune system in the gastrointestinal tract plays a crucial role in the control of infection, as it constitutes the first line of defense against mucosal pathogens. The attractive features of oral immunization have led to the exploration of a variety of oral delivery systems. However, none of these oral delivery systems have been applied to existing commercial vaccines. To overcome this, a new generation of oral vaccine delivery systems that target antigens to gut-associated lymphoid tissue is required. One promising approach is to exploit the potential of microfold (M) cells by mimicking the entry of pathogens into these cells. Targeting specific receptors on the apical surface of M cells might enhance the entry of antigens, initiating the immune response and consequently leading to protection against mucosal pathogens. In this article, we briefly review the challenges associated with current oral vaccine delivery systems and discuss strategies that might potentially target mouse and human intestinal M cells.
引用
收藏
页数:7
相关论文
共 108 条
[1]   Impact of chitosan coating of anionic liposomes on clearance rate, mucosal and systemic immune responses following nasal administration in rabbits [J].
Amin, Mohamadreza ;
Jaafari, Mahmoud Reza ;
Tafaghodi, Mohsen .
COLLOIDS AND SURFACES B-BIOINTERFACES, 2009, 74 (01) :225-229
[2]   Induction of broad cross-subtype-specific HIV-1 immune responses by a novel multivalent HIV-1 peptide vaccine in cynomolgus macaques [J].
Azizi, Ali ;
Anderson, David E. ;
Torres, Jose V. ;
Ogrel, Andrei ;
Ghorbani, Masoud ;
Soare, Catalina ;
Sandstrom, Paul ;
Fournier, Jocelyne ;
Diaz-Mitoma, Francisco .
JOURNAL OF IMMUNOLOGY, 2008, 180 (04) :2174-2186
[3]   Viral peptide immunogens: current challenges and opportunities [J].
Azizi, Ali ;
Diaz-Mitoma, Francisco .
JOURNAL OF PEPTIDE SCIENCE, 2007, 13 (12) :776-786
[4]   Mucosal HIV vaccines: A holy grail or a dud? [J].
Azizi, Ali ;
Ghunaim, Haitham ;
Diaz-Mitoma, Francisco ;
Mestecky, Jiri .
VACCINE, 2010, 28 (24) :4015-4026
[5]   Mucosal vaccination against bacterial respiratory infections [J].
Baumann, Ulrich .
EXPERT REVIEW OF VACCINES, 2008, 7 (08) :1257-1276
[6]   Intranasal vaccination of humans with recombinant cholera toxin B subunit induces systemic and local antibody responses in the upper respiratory tract and the vagina [J].
Bergquist, C ;
Johansson, EL ;
Lagergard, T ;
Holmgren, J ;
Rudin, A .
INFECTION AND IMMUNITY, 1997, 65 (07) :2676-2684
[7]   Evaluation of the immune response following a short oral vaccination schedule with hepatitis B antigen encapsulated into alginate-coated chitosan nanoparticles [J].
Borges, Olga ;
Tavares, Joana ;
de Sousa, Adriano ;
Borchard, Gerrit ;
Junginger, Hans E. ;
Cordeiro-da-Silva, Anabela .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2007, 32 (4-5) :278-290
[8]   Receptor binding studies disclose a novel class of high-affinity inhibitors of the Escherichia coli FimH adhesin [J].
Bouckaert, J ;
Berglund, J ;
Schembri, M ;
De Genst, E ;
Cools, L ;
Wuhrer, M ;
Hung, CS ;
Pinkner, J ;
Slättegård, R ;
Zavialov, A ;
Choudhury, D ;
Langermann, S ;
Hultgren, SJ ;
Wyns, L ;
Klemm, P ;
Oscarson, S ;
Knight, SD ;
De Greve, H .
MOLECULAR MICROBIOLOGY, 2005, 55 (02) :441-455
[9]   DNA prime Listeria boost induces a cellular immune response to SIV antigens in the rhesus macaque model that is capable of limited suppression of SIV239 viral replication [J].
Boyer, JD ;
Robinson, TM ;
Maciag, PC ;
Peng, XH ;
Johnson, RS ;
Pavlakis, G ;
Lewis, MG ;
Shen, AD ;
Siliciano, R ;
Browne, CR ;
Weiner, DB ;
Paterson, Y .
VIROLOGY, 2005, 333 (01) :88-101
[10]   Oral vaccination with LcrV from Yersinia pestis KIM delivered by live attenuated Salmonella enterica serovar Typhimurium elicits a protective immune response against challenge with Yersinia pseudotuberculosis and Yersinia enterocolitica [J].
Branger, Christine G. ;
Torres-Escobar, Ascencion ;
Sun, Wei ;
Perry, Robert ;
Fetherston, Jacqueline ;
Roland, Kenneth L. ;
Curtiss, Roy, III .
VACCINE, 2009, 27 (39) :5363-5370